Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic immunodeficiency disorders.

Amy S Paller1

  • 1Department of Pediatrics, Children's Memorial Hospital, Northwestern University's Feinberg School of Medicine, Chicago, IL 60614, USA. apaller@northwestern.edu

Clinics in Dermatology
|February 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis.

JCI insight·2025
Same author

Characteristics of youth utilizing pediatric dermatology: A cross-sectional PEDSnet study.

Journal of the American Academy of Dermatology·2025
Same author

Facial Rash Events in Dupilumab Phase 3 Atopic Dermatitis Trials: A Pooled Analysis.

Dermatitis : contact, atopic, occupational, drug·2025
Same author

Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.

JAMA dermatology·2025
Same author

Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

Pediatric dermatology·2025
Same author

Prevalence and Trends in Systemic Treatment for Pediatric Psoriasis in the USA between 2015 and 2021.

Dermatology and therapy·2025
Same journal

Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

Clinics in dermatology·2026
Same journal

Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

Clinics in dermatology·2026
Same journal

Tanorexia: The Psychodermatology of Compulsive Tanning.

Clinics in dermatology·2026
Same journal

Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

Clinics in dermatology·2026
Same journal

Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

Clinics in dermatology·2026
Same journal

Sherlock Holmes and the mystery of the deadly diet.

Clinics in dermatology·2026
See all related articles

Cutaneous signs like hair loss and skin infections can signal immunodeficiency disorders in children. Early diagnosis aids in managing infections and cancer risks associated with these conditions.

Area of Science:

  • Immunology
  • Dermatology
  • Genetics

Background:

  • Immunodeficiency disorders present with distinctive cutaneous manifestations.
  • Skin abnormalities can be key diagnostic indicators for immunodeficiencies.
  • These disorders increase susceptibility to infections and malignancies.

Purpose of the Study:

  • To review immunodeficiency disorders with notable cutaneous signs.
  • To highlight the diagnostic role of skin abnormalities in immunodeficiencies.
  • To discuss the implications for patient management and genetic counseling.

Main Methods:

  • Review of selected immunodeficiency disorders.
  • Analysis of characteristic cutaneous findings.
  • Discussion of clinical presentation and diagnostic criteria.

Related Experiment Videos

Main Results:

  • Specific skin abnormalities include alopecia, granulomas, infections, dermatitis, purpura, pigmentation changes, poor wound healing, and telangiectasias.
  • Recurrent, prolonged, or unusual infections suggest immunodeficiency.
  • Patients face a significantly elevated risk of malignancy.

Conclusions:

  • Cutaneous signs are crucial for diagnosing immunodeficiency disorders.
  • Understanding the molecular basis improves genetic counseling and prenatal diagnosis.
  • Early recognition and management are vital for improving patient outcomes.